This article is intended for primary care clinicians, pain specialists, anesthesiologists, oncologists, orthopedists, emergency department clinicians, and other specialists who care for patients who experience pain.
The goal of this activity is to provide medical news to primary care clinicians and other healthcare professionals in order to enhance patient care.
Upon completion of this activity, participants will be able to:
As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 0.25
AMA PRA Category 1 Credit(s)
. Physicians should only claim credit commensurate with the extent of their participation in the activity. Medscape Medical News has been reviewed and is acceptable for up to 300 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins 09/01/07. Term of approval is for 1 year from this date. This activity is approved for 0.25 Prescribed credits. Credit may be claimed for 1 year from the date of this activity. AAFP credit is subject to change based on topic selection throughout the accreditation year.
This Activity is sponsored by Medscape Continuing Education Provider Unit.
Medscape is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
Awarded 0.25 contact hour(s) of continuing nursing education for RNs
and APNs; None of these credits is in the area of pharmacology.
Provider Number: 6FDKKC-PRV-05
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 5 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CME / CE Released: 9/20/2007; Reviewed and Renewed: 10/17/2008
Valid for credit through: 10/17/2009
processing....
September 20, 2007 -- In the primary care setting, the pain numeric rating scale to screen for pain was only moderately accurate in identifying pain in patients, according to the results of a study reported in the August 1 Online First issue and will appear in the October print issue of the Journal of General Internal Medicine.
"Universal pain screening with a 0-10 pain intensity numeric rating scale (NRS) has been widely implemented in primary care," write Erin E. Krebs, MD, MPH, from the Center on Implementing Evidence-Based Practice, Roudebush Veterans Affairs Medical Center in Indianapolis, Indiana, and colleagues. "Universal screening in primary care would be useful if it accurately identified patients with clinically important pain who could potentially benefit from additional pain assessment and management.... The U.S. Preventive Services Task Force (USPSTF) recommends that two criteria be met before a screening test is recommended for widespread use: (1) the test should be sufficiently accurate and capable of detecting a condition earlier than routine care and, (2) screening and early treatment should improve the likelihood of favorable patient outcomes."
In this prospective, diagnostic accuracy study, 275 adult clinic patients were enrolled from September 2005 to March 2006 and were tested for clinically important pain with the use of 2 alternate definitions: pain interfering with functioning (Brief Pain Inventory interference scale [BPI] ≥ 5) and pain motivating a visit to the clinician or being the patient-reported reason for the visit.
A pain symptom being the main reason for a visit to the clinician was reported by 22% of patients, with the most frequently reported pain locations being in the lower extremity (21%) and back or neck (18%).
As a test for pain that interferes with functioning, the NRS had fair accuracy, with an area under the receiver operator characteristic (ROC) curve of 0.76. A pain screening NRS score of 1 was 69% sensitive for pain that interferes with functioning (95% confidence interval [CI], 60 - 78), and multilevel likelihood ratios for scores of 0, 1 to 3, 4 to 6, and 7 to 10 were 0.39 (95% CI, 0.29 - 0.53), 0.99 (95% CI, 0.38 - 2.60), 2.67 (95% CI, 1.56 - 4.57), and 5.60 (95% CI, 3.06 - 10.26), respectively.
Use of the alternate definition of pain that motivates a visit to the clinician yielded similar results.
Limitations of the study include the absence of a well-established gold standard for clinically important pain, potential selection bias, and lack of generalizability to all primary care settings.
"The practice of universal pain screening has become widespread despite a lack of published research evaluating the accuracy and effectiveness of pain screening strategies," the study authors conclude. "Our results suggest that the most commonly used measure for pain screening may have only modest accuracy for identifying patients with clinically important pain in primary care. Further research is needed to determine whether pain screening improves patient outcomes in primary care."
The Robert Wood Johnson Foundation provided funding for this study through the Clinical Scholars Program and supported one of its authors. The remaining authors have disclosed financial relationships with the National Institutes of Health and the Department of Veterans Affairs.
J Gen Intern Med. Published online August 1, 2007.
October 2007;00:000-000.
Approximately 20% of primary care patients experience chronic pain, and pain screening is intended to improve the quality of pain management by systematically identifying patients with pain in clinical settings, but currently there is no commonly accepted gold standard for clinically important pain. The NRS on which patients rate their pain as 0 ("no pain") to 10 ("worst pain") has become the most widely used instrument for pain screening. The potential advantages of the NRS are it is short, easy to administer, and is validated as a measure of intensity of pain in populations with known pain. However, no studies have evaluated its accuracy as a screening test to identify patients with clinically important pain.
This is a prospective diagnostic accuracy study of consecutive patients presenting to a primary care outpatient clinic to compare the NRS used as a screening tool with 2 functional measures of pain: the BPI interference scale and a question on pain that motivates a visit to the clinician.